Author:
Margolis K. L., ,Bonds D. E.,Rodabough R. J.,Tinker L.,Phillips L. S.,Allen C.,Bassford T.,Burke G.,Torrens J.,Howard B. V.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference61 articles.
1. Mokdad A, Ford E, Bowman B et al. (2003) Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 289:76–79
2. Espeland M, Hogan P, Fineberg S et al. (1998) Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 21:1589–1595
3. Writing group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199–208
4. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB (1992) Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74:1396–1400
5. Lobo R, Pickar J, Wild R, Walsh B, Hirvonen E (1994) Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol 84:987–995